Camber_logo (Camberlogo)
Diatrizoate Meglumine And Diatrizoate Sodium Solution
Product Images NDC 31722-019
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Diatrizoate Meglumine And Diatrizoate Sodium (NDC 31722-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Dmds-120ml-label (Dmds 120ml Label)
Label for Diatrizoate Meglumine and Diatrizoate Sodium Solution, USP, oral or rectal use, 120 mL single dose bottle. Contains 37% organically bound iodine, with 660 mg diatrizoate meglumine and 100 mg diatrizoate sodium per mL. Labeler is Camber Pharmaceuticals, Inc. Warning: Do not inject. Includes storage and usage instructions and barcode.*
Dmds-120ml-shipper-label (Dmds 120ml Shipper Label)
Diatrizoate Meglumine and Diatrizoate Sodium Solution, USP, 660 mg/mL and 100 mg/mL, oral or rectal use only. The label from Camber Pharmaceuticals, Inc. indicates 12 bottles of 120 mL each, with warnings not to inject and to discard unused portions. Storage instructions specify 20° to 25°C, with protection from light. Packaging is marked for gastrointestinal radiography use only.*
Dmds-30ml-label (Dmds 30ml Label)
Label for Diatrizoate Meglumine and Diatrizoate Sodium Solution, USP, 30 mL, an oral or rectal solution containing 660 mg diatrizoate meglumine and 100 mg diatrizoate sodium per mL. The label specifies 37% organically bound iodine, indicates it is a single dose bottle for gastrointestinal radiography, and emphasizes DO NOT INJECT. Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ.*
Dmds-30ml-shipper-label (Dmds 30ml Shipper Label)
Label for Diatrizoate Meglumine and Diatrizoate Sodium Solution USP, containing 660 mg diatrizoate meglumine and 100 mg diatrizoate sodium per mL. It is a liquid solution for oral or rectal use only, distributed in 24 bottles of 30 mL each by Camber Pharmaceuticals, Inc. The label warns against injection and indicates 37% organically bound iodine content.*
Structure-2 (Structure 2)
Chemical structure of Diatrizoate Meglumine and Diatrizoate Sodium, showing its iodine-substituted benzene ring with attached amide and acetyl groups, including the sodium salt moiety.*
Structure (Structure)
Chemical structure diagrams depicting the molecular formulas of Diatrizoate Meglumine and Diatrizoate Sodium, the active ingredients in the solution product by Camber Pharmaceuticals, Inc.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
